Mimetas is a company that develops organ-on-a-chip tissue models for evaluating drugs, chemicals, and food components. Its microfluidic technology, designated OrganoPlates, enables testing of compounds in high-throughput on miniaturized organ models. The OrganoPlate platform supports 3D cell culture under continuous perfusion and membrane-free co-culture, including epithelial and endothelial boundary tissues.